Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New protocol for outbreaks of CEM
Taylorella equigenitalis, the bacterium that causes CEM, can be passed through natural mating and artificial insemination.
Highly contagious disease remains ‘a very real threat’

A new protocol has been implemented for controlling future outbreaks of contagious equine metritis (CEM) in England, Scotland and Wales.

Suspected cases must still be reported to the APHA, but the owners of affected horses will now be able to use a private equine veterinary surgeon - who has been specifically approved to deal with the disease - without official movement restrictions being imposed.

This arrangement requires compliance with control measures outlined in the Horserace Betting Levy Board’s code of practice for CEM. All associated costs will continue to be covered by the horse owner.

Taylorella equigenitalis, the bacterium that causes CEM, can be passed through natural mating and artificial insemination. It causes sub-fertility in affected mares and stallions can carry it without showing clinical signs, leading to chronic infection.

The new protocol was developed by the Equine Disease Coalition, which is chaired by World Horse Welfare and comprises representatives from the APHA, Animal Health Trust, BEVA, Defra and devolved administrations, Nottingham vet school, RSPCA and RVC.

BEVA chief executive David Mountford said: “Whilst occurrences of CEM are sporadic and we have not had any confirmed cases in the UK since 2012, it still presents a very real threat to our breeding industry.   

“Ensuring cases are treated and managed by an approved veterinary surgeon, who is fully versed in the HBLB Code of Practice, guarantees that the appropriate provisions will be taken in order to safeguard our world class breeding population.”

Professor Sidney Ricketts, joint veterinary adviser for the Thoroughbred Breeders Association, warned that while there have not been any UK cases for a number of years - largely because of compliance with the HBLB code of practice - infections are regularly found in many other countries.

“So there is a continued risk from carrier or infected mares or stallions being imported into the UK,” he added. “The new control measures are a vital tool in helping manage this risk.” 

The AHT will have a central role in the protocol, co-ordinating activities undertaken by approved vets, receiving and collating reports, initiating tracing processes off affected premises and taking responsibility for epidemiological investigations.

Horse owners and laboratories should report suspected cases to the Defra Rural Services helpline, on 03000 200 310.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.